European Pharmaceutical Stocks Follow U.S. Peers Down -- Market Talk
Dow Jones01-28
1014 GMT - European pharmaceutical stocks fall in early European trade, following their U.S. peers after the U.S. Medicare agency proposed to pay domestic insurers well below what analysts were expecting in 2027. After $96 billion of U.S. healthcare market capitalization was wiped out Tuesday, European pharmaceutical stocks fall, too. Sandoz Group leads the sector down--falling 3.3%--while German chemicals giant Bayer drops 2.8%. Roche Holding falls 2.7%, as Novo Nordisk and GSK both fall over 2%. (josephmichael.stonor@wsj.com)
(END) Dow Jones Newswires
January 28, 2026 05:17 ET (10:17 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments